Drug therapy for coronary heart disease: the Sheffield table

Slides:

Advertisements

Similar presentations

Toward a Structure Determination Method for Biomineral-Associated Protein Using Combined Solid- State NMR and Computational Structure Prediction David.

Advertisements

How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Pharmacogenetics and future drug development and delivery

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

The benefits and harms of breast cancer screening

Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis Sarah A. Anderson, John.

Mental illness and mental health

Punishment beatings and the rule of law

John N Nkengasong, Philip Onyebujoh The Lancet

Frailty assessment in elderly people

Cervical cancer incidence can increase despite HPV vaccination

Long-term effects of hormone replacement therapy

Gareth L Ackland, Maurizio Cecconi, Rupert M Pearse

A twin with Cushing's disease

Political factors behind US global AIDS programmes slow-down

Aspirin in the prevention of cancer – Author's reply

Volume 376, Issue 9754, (November 2010)

Gene therapy in haematology and oncology

What does STOP-2 tell us about management of hypertension?

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Myth of the menopause paradox

Gene therapy—where are we?

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta- analysis of individual participant data from randomised trials

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.

SNPs and coronary heart disease – Authors' reply

Statins for prevention of stroke

Physiological hazards of flight at high altitude

Brian J Coburn, Sally Blower The Lancet Infectious Diseases

Can famine relief meet health and hunger goals simultaneously?

Punishment beatings and the rule of law

Can plagues be predicted, prevented?

Organisation of the care of patients with heart failure

Disease and stigma The Lancet Volume 354, (December 1999)

Allergen exposure and asthma

Arnaud Chiolero The Lancet Public Health

HIV myths should not be resuscitated

Volume 352, Pages S15-S18 (October 1998)

General Practice Research Database for prescribing analysis

Ngoc Minh Pham, Chung Thanh Nguyen, Colin W Binns, Andy H Lee

Successes and failures of current treatment of heart failure

Volume 362, Pages s6-s7 (December 2003)

Assessment of herd immunity from human papillomavirus vaccination

What would happen if we stopped vaccination?

MRC/BHF Heart Protection Study

Confessions of a journal junkie

Sven Pischke, Patrick Behrendt, Michael P Manns, Heiner Wedemeyer

Telling it like it isn't: truth and lies in a post-9/11 world

Volume 382, Issue 9894, Pages (August 2013)

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study Heart Protection.

Thank God for Richard Dawkins?

Seeking asylum, losing hope

Low-technology approaches

ACST: which subgroups will benefit most from carotid endarterectomy?

Volume 383, Issue 9921, Pages (March 2014)

Sunku H Guptha, Eric Holroyd, Gordon Campbell

Procalcitonin as a diagnostic marker for sepsis

Inhaled triple therapy in chronic obstructive pulmonary disease

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Costs of eliminating HIV in South Africa have been underestimated

Volume 9, Issue 6, (December 2011)

Genetic enhancement of radionuclide cancer therapy

Stem cell transplantation

Political factors behind US global AIDS programmes slow-down

Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)

Effect of consent rituals on mortality in emergency care research

Symptom-based stratification of autoimmune diseases

A disease of the osteoblast

Presentation transcript:

Drug therapy for coronary heart disease: the Sheffield table Patrick Vallance, John Martin The Lancet Volume 350, Issue 9094, (December 1997) DOI: 10.1016/S0140-6736(05)63674-4 Copyright © 1997 Elsevier Ltd Terms and Conditions

Figure Computer screen used during consultation Patient's data are entered and the histogram depicts the absolute risk of coronary heart disease or stroke in a 10-year period. This example shows the predicted benefit of stopping smoking and a reduction in cholestrol from 6·4 mmol/L to 5·8 mmol/L. LVH=left-ventricular hypertrophy Theoretical risk after proposed intervention The Lancet 1997 350, DOI: (10.1016/S0140-6736(05)63674-4) Copyright © 1997 Elsevier Ltd Terms and Conditions